The Asian Smart Medical Online Exhibition 2026, organized by AsianNet and TradeAsia, kicks off a four-month hybrid event aligning with global healthcare conferences to boost B2B medical trade.[1]

Epsilon Healthcare signs a three-year manufacturing agreement with Puro to produce GMP-certified pharmaceutical products for export to the UK and other European markets, projecting AU$2M revenue in 2026.

Healthcare analysts predict an increase in U.S. hospital mergers and acquisitions in 2026 following a slowdown in 2025, driven by policy clarity and financial pressures, though levels remain uncertain.[1]

Siloam Hospitals in Indonesia has installed the da Vinci Xi robotic-assisted surgery system, marking the first rollout of this advanced technology in the country to enhance surgical precision.

Flat Medical achieves major milestones with its EpiFaith Smart Syringe securing a framework agreement with UK NHS Supply Chain and a clinical order from Europe's largest hospital system AP-HP in France.

President Trump has signed a $1.2 trillion legislative package that includes sweeping pharmacy benefit manager reforms and continued funding for HHS, impacting hospital drug pricing and operations.

The Philippines' Asian Hospital and Medical Centre clinched Philippines Innovator of the Year - Healthcare and Team of the Year - Healthcare at the 2026 awards for its Asian Cancer Institute's operational successes and CyberKnife S7 deployment.

EHMA has published a new report advocating for digital solutions to enhance medication management and prevent shortages in European hospitals.

Healthcare executives anticipate a surge in hospital mergers and acquisitions in 2026 as systems gain clarity on Trump administration policies, though uncertainty and distress sales temper expectations.

Berlin-based Recare has raised €37 million to deploy its AI agent that automates hospital discharge workflows, targeting expansion beyond Germany amid healthcare staffing shortages.